isotretinoin gx isotretinoin10mg capsule blister pack
southern cross pharma pty ltd - isotretinoin, quantity: 10 mg - capsule, soft - excipient ingredients: soya oil; yellow beeswax; hydrogenated soya oil; partially hydrogenated soya oil; gelatin; glycerol; titanium dioxide; iron oxide red; iron oxide yellow; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution - treatment of severe cystic acne. a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.
pharmacor isotretinoin isotretinoin 20mg capsule blister pack
southern cross pharma pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: soya oil; yellow beeswax; hydrogenated soya oil; partially hydrogenated soya oil; gelatin; glycerol; titanium dioxide; iron oxide red; iron oxide yellow; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution - treatment of severe cystic acne. a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.
isotretinoin lupin isotretinoin 20 mg capsule blister pack
southern cross pharma pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: soya oil; yellow beeswax; hydrogenated soya oil; partially hydrogenated soya oil; gelatin; glycerol; titanium dioxide; iron oxide red; iron oxide yellow; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution - treatment of severe cystic acne. a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.
isotretinoin lupin isotretinoin10 mg capsule blister pack
southern cross pharma pty ltd - isotretinoin, quantity: 10 mg - capsule, soft - excipient ingredients: soya oil; yellow beeswax; hydrogenated soya oil; partially hydrogenated soya oil; gelatin; glycerol; titanium dioxide; iron oxide red; iron oxide yellow; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution - treatment of severe cystic acne. a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.
linevox linezolid 600mg tablet blister pack
arrotex pharmaceuticals pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; microcrystalline cellulose; magnesium stearate; purified talc; poloxamer; colloidal anhydrous silica; sodium starch glycollate type a; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution; titanium dioxide; hypromellose; macrogol 400 - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. ,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected
podoxred 100mg lyophilized powder for injection (iv infusion)
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - pemetrexed (as disodium) - lyophilized powder for injection (iv infusion) - 100mg
podoxred 500mg lyophilized powder for injection (iv infusion)
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - pemetrexed (as disodium) - lyophilized powder for injection (iv infusion) - 500mg
myborte 3.5mg lyophlized powder for iv infusion
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - bortezomib - lyophlized powder for iv infusion - 3.5mg
none 500 mg powder for injection (iv/im)
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - ceftriaxone (as sodium) - powder for injection (iv/im) - 500 mg
none 1 g powder for injection (iv/im)
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - ceftriaxone (as sodium) - powder for injection (iv/im) - 1 g